(Dab7)-Leiurotoxin I is a modified form of the venom peptide Leiurotoxin I with a D-amino acid substitution at position 7. The substitution enhances stability and receptor binding properties. Researchers use this peptide to investigate its neurotoxic effects, particularly in relation to ion channel inhibition and its potential use as a model in toxin-receptor interaction studies.
CAT No: L02002
CAS No:1061556-49-7
Synonyms/Alias:(DAB7)-LEIUROTOXIN I;1061556-49-7;Lei-Dab 7 TFA;DA-54846;
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.